drugset / Trial / NCT00541723
Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital Wrinkles
RandomizedParallel-groupTriple-blindTreatment
Summary
To investigate the efficacy and safety of incobotulinumtoxinA (Xeomin) in comparison to placebo in the treatment of moderate to severe lateral periorbital wrinkles at maximum smile and to compare two different application schemes of Xeomin. Each subject will be treated on the right and left eye area, using the same dose but different application schemes (i.e. 3 or 4 injection sites).
Timeline
- Start
- 2007-09
- Primary completion
- 2008-02
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 12 iu | Intramuscular |
Indications
No indication recorded.